METHOD TO TREAT INVOLUTIONAL MOIST CHORIORETINAL DYSTROPHIA

FIELD: medicine, ophthalmology. SUBSTANCE: method deals with a multirow peripheral argon-laser coagulation along with vasoreconstruction of retinal peripheral arteries at the mode of 250-350 milliwatt and 0.07-0.1 second exposure. Then 1-2 weeks later 2-3 barrages and coagulation of central retinal...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PANKOVA O.P, ROMASHENKOV F.A, SEMENOV A.D, DEEV L.A, SHERDIS N.F
Format:	Patent
Sprache:	eng
Schlagworte:	BANDAGES, DRESSINGS OR ABSORBENT PADS DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS DIAGNOSIS ELECTROTHERAPY FILTERS IMPLANTABLE INTO BLOOD VESSELS FIRST-AID KITS FOMENTATION HUMAN NECESSITIES HYGIENE IDENTIFICATION MAGNETOTHERAPY MEDICAL OR VETERINARY SCIENCE ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES PROSTHESES RADIATION THERAPY SURGERY TREATMENT OR PROTECTION OF EYES OR EARS ULTRASOUND THERAPY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, ophthalmology. SUBSTANCE: method deals with a multirow peripheral argon-laser coagulation along with vasoreconstruction of retinal peripheral arteries at the mode of 250-350 milliwatt and 0.07-0.1 second exposure. Then 1-2 weeks later 2-3 barrages and coagulation of central retinal departments as dependent upon edema spreading are conducted stage by stage at 1-2-week-long intervals. In area of vessels of the second order - at the mode of 250-350 milliwatt and 0.05-0.1 second exposure and macula diameter of 100 mcm. Then the second and the third barrages are carried out in area of vessels of the third order and terminal branching of paramacular vessels at the mode of 200-300 milliwatt and 0.05-0.1 second exposure and macula diameter of 50 mcm. EFFECT: higher efficiency of therapy.